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A review is made of the various histological lesions observed in hepatitis B virus-related liver
diseases, including different forms of acute and chronic hepatitis, cirrhosis, and hepatocellular
carcinoma. The elementary lesions discussed include acidophil necrosis (apoptosis), confluent
lytic necrosis in its different patterns, piecemeal necrosis, focal necrosis, and dysplastic hepato-
cytes. Their pathogenesis is explained in the framework ofrecent developments in the immunopa-
thology ofhepatitis B viral infections.
INTRODUCTION
Infection with the hepatitis B virus (HBV) results in a broad variety of clinical
diseases. Evidence supporting this clinical experience came from transmission studies
in volunteers nearly half a century ago, in which identical inocula of HBV were
injected into healthy recipients and resulted in different clinical responses [1,2].
In 1972, it was first suggested [3] that HBV is not directly cytopathic to the
hepatocyte, and that hepatic inflammation and liver cell damage are mediated by
various immunological mechanisms. The thesis that host immunity is most important
in the causation of liver damage has gained considerable support [4,5], although the
factors which determine a particular syndrome in the individual patient remain largely
unknown, and direct cytotoxicity ofthevirus on liver parenchymal cells is not excluded
[6,7].
Thevarious hepatic diseases which may result from HBV infection are shown in Fig
1. This paper reviews the main histopathological liver lesions and their presumed
pathogenic mechanisms.
ACUTE VIRAL HEPATITIS B
Acute viral hepatitis B may take the form of a mild disease, either subclinical,
anicteric infection or classical icteric hepatitis with spontaneous recovery, or it may
present more rarely as a severely necrotizing, life-threatening disease.
All forms of acute viral hepatitis B apparently result from an adequate response of
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the host's immune defense, resulting in complete elimination of the virus; acute viral
hepatitis B thus represents an "elimination type" of hepatitis [8]. Eradication of the
virus implies, however, elimination of virus-infected hepatocytes; this fact is reflected
in the complex array of histological lesions observed, including parenchymal damage,
hepatocellular necrosis, liver cell regeneration, and inflammatory infiltration.
CLASSICAL ACUTE HEPATITIS WITH RECOVERY
The histological lesion in uncomplicated acute hepatitis B is a complex one. The
sinusoids are crowded with increased numbers of mononuclear cells, mainly macro-
phages and lymphocytes, with highest density in acinar zone 3. This increased
sinusoidal cellularity reflects the intrahepatic immunological reaction against the
virus. The sinusoidal lining cells and macrophages have been shown to express strongly
HLA-DR or HLA class II antigens [9]. These cells are presumed to function as
antigen-presenting cells to T-helper lymphocytes [10].
In order to react tothe foreign viral antigen, T-helper lymphocytes need to "see" this
antigen in conjunction with self antigens (HLA class II antigens) expressed on the
surface of "accessory" or antigen-presenting cells (often indicated by the vague term
"macrophages"). The latter secrete the lymphokine interleukin 1, which activates the
helper T lymphocytes (Fig. 2). Activated T-helper lymphocytes in turn activate
cytotoxic T cells and B lymphocytes through secretion ofthe lymphokine interleukin 2
(Fig. 2).
Infected hepatocytes supporting viral replication express part oftheviral antigens at
their plasma membranes: both hepatitis B surface antigen (HBsAg) and hepatitis B
coreantigen (HBcAg) have been demonstrated on thesurfaceofmechanically isolated
hepatocytes in acute viral hepatitis B [11]. In addition to expressing viral antigens, the
hepatocyte is also triggered to display at its surface HLA A,B,C (or HLA class I)
antigens, which are not expressed on liver parenchymal cells in the normal state
[9,12,13].
In this way, the stage is set for a cytotoxic T-cell attack toviral antigens expressed on
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antigen RIF: rosette inhibitory factor T4: helper-inducer lymphocyte T8: suppressor-cytotoxic lym-
phocyte For explanation, see text.
the liver cell's surface, since cytotoxic T cells can now "see" the foreign viral antigen to
which they are sensitized in conjunction with the HLA class I antigens. The latter is a
necessary constraint of major histocompatibility complex (MHC) compatibility in
order to assure their effective reaction [14,15].
On the basis of published histological and immunohistochemical observations, it
appears that immunologic elimination of HBV-infected hepatocytes might be
mediated by cytotoxic T lymphocytes. Such a mechanism was demonstrated in an
elegant animal model of mouse hepatitis [16], and evidence in support of similar
mechanisms in human acute viral hepatitis B was recently produced by functional
immunologic studies [11].
Immunohistochemical analysis of lymphocyte subsets in acute viral hepatitis B
revealed, however, that the infiltrating lymphocytes are not exclusively composed of
OKT8+ cytotoxic T lymphocytes; the predominant lymphocyte subset corresponds to
natural killer (NK) lymphocytes, which show no genetic restriction and do not require
HLA class I antigen display on the target cells [17]. Also, recent functional
immunological studies suggest involvement ofNK cells [11,18]. These observations fit
with what is known in other viral infections, that NK cells are the first line ofdefense
against viral infection.
The result of the lymphocyte attack-either by cytotoxic T cells or natural killer
cells or both-is a killing ofthe target cell.
The mode of cell death in immune-mediated target cell lysis is not classical cell
necrosis, but apoptosis [19]. Apoptosis is a special pre-programmed and active mode of
cell death. A precise sequence of intracellular changes occurs, including condensation
and margination ofthe nuclear chromatin and formation ofnumerous blebs at the cell
surface, but the intracellular organelles remain well preserved in contrast to what
happens in classical cell necrosis. Finally, the cell breaks down into several fragments
surrounded by a membrane.
Under the light microscope, apoptosis can be recognized as smaller and larger
eosinophilic cell fragments, occasionally containing a pycnotic nucleus (Fig. 3). These
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FIG. 4. Schematic drawing of the acinar and lobular concepts of liver architec-
ture. Black triangles represent portal tracts, open circles central veins. The
central hexagon, delineated by interrupted lines and centered by a portal tract,
represents a complex acinus, composed of three simple acini which are centered by a
terminal portal venule (continuous line). Each simple acinus can be subdivided in
acinar zones 1, 2, and 3, the latter representing the microcirculatory periphery.
Necrosis in the periphery of the complex acinus leads to central-central bridging
necrosis. Necrosis in the periphery of the simple acinus (zone 3) leads to
portal-central bridging necrosis (shaded area). This pattern of necrosis creates a
star-shaped area of necrosis from the point of view of the classical hexagonal liver
lobule (left hexagon, centered by central vein).
apoptotic bodies become phagocytosed very soon by neighboring parenchymal cells
and by nearby macrophages [20]. Close inspection of liver biopsies taken in patients
with acute viral hepatitis B reveals numerous apoptotic bodies in close relationship
with lymphocytes. Obviously, it is more difficult to identify the smaller apoptotic
bodies, whereas the larger apoptotic fragments are easily recognized. The latter were
known for many years as "acidophil necrosis," "acidophil bodies," or "Councilman-
like bodies" [21] (Fig. 3).
Research on apoptosis has revealed that what was usually considered as single-cell
necrosis does not at all correspond to classical cell necrosis but instead represents a
lymphocyte-induced triggering of a pre-set program for active self-destruction of the
liver cell [22].
Activated lymphocytes release several lymphokines; one ofthese soluble factors is a
cholestasis-inducing lymphokine [23]. This finding may at least in part explain the
occurrence of microscopic features of cholestasis in most liver biopsies from patients
with acute hepatitis B (Fig. 3).
Not all damaged hepatocytes appear as small, shrunken apoptotic bodies in acute
viral hepatitis B. One of the most striking features of the histopathological picture is
liver cell pleomorphism, most pronounced in acinar zone 3 [21]. Several hepatocytes
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appear enlarged and pale, corresponding to "hydropic swelling" or "ballooning of
hepatocytes" (Figs. 3,7). Hydropic swelling is believed to be a precursor stage oflytic
necrosis of hepatocytes. The precise mechanism of this type ofhepatocellular damage
and death is not well known, but there is reason to assume that the primary damage is
at the cell membrane [24]. It is this variety ofcell damage with leaky cell membranes,
which probably is most responsible for the release of intracellular enzymes and which
contributes to the rise ofserum transaminases.
Lytic necrosis ofhepatocytes is a rapid event; thecell disappears in a very short time.
Hence it follows that lytic necrosis is recognized histologically as an absence of cells.
This condition is often described as "drop-out ofliver cells," resulting in denudation of
the reticulin framework. Lytic necrosis usually affects groups of hepatocytes, leading
to the disappearance of confluent areas of parenchyma; this fact explains the term
"confluent necrosis" [25].
SEVERE ACUTE VIRAL HEPATITIS B (SUBACUTE HEPATIC
NECROSIS; FULMINANT HEPATITIS)
Confluent necrosis may affect smaller or larger parenchymal territories. When
confluent necrosis destroys larger portions of parenchyma, the acute hepatitis is
usually of a clinically more severe type, designated as subacute hepatic necrosis and
fulminant hepatitis (Fig. 1). One ofthe remarkable features ofconfluent lytic necrosis
is that it occurs in well-defined areas of the liver parenchyma: it shows a predilection
for the microcirculatory periphery [26].
The microcirculatory periphery of the liver parenchyma is better explained by the
acinar concept of liver architecture, according to Rappaport, than by the classical
lobular concept according to Kiernan [27] (Fig. 4).
Confluent lytic necrosis in the microcirculatory periphery of the complex acinus
leads to necrotic bridges between adjacent central veins (central-central bridging
necrosis) (Figs. 4,5); whereas confluent necrosis in the microcirculatory periphery of
thesimple acinus (or acinar zone 3) creates necrotic bridging between portal tracts and
central veins (portal-central bridging necrosis) (Figs. 4,6,7). The latter corresponds, at
the lobular level, to a star-shaped area ofnecrosis linking portal tracts and centralveins
[27] (Figs. 4,6).
These patterns of necrosis correspond to what is often termed "bridging hepatic
necrosis" [28]. When still larger masses of parenchymal cells succumb to confluent
lytic necrosis, thedrop-out oflivercellsextends to zone 2 (Fig. 8), and even upto zone 1
of the simple acini, resulting in total destruction of all parenchyma of the liver units:
panlobular and multilobular necrosis (Fig. 9). Very often, multilobular necrosis
displays an irregular distribution throughout the liver, apparently corresponding to
total destruction of some acinar agglomerates, whereas adjacent larger parenchymal
units (or acinar agglomerates) are spared.
This predilection of confluent lytic necrosis to occur first in peripheral areas of the
microcirculation, the apparent relationship of multilobular necrosis to hepatic angio-
architecture, and the relative scarcityoflymphocytes in thedenuded areas are features
which suggest that in this mode of necrosis other mechanisms are involved than those
in focal apoptotic cell death.
The most plausible mechanism is a humoral one, possibly circulating antibodies or
immune complexes, associated with activation of complement. Complement compo-
nents (the complement C5b-9m complex) has been shown to cause a lytic type of
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necrosis, since it behaves like a membrane-piercing protein [29,30]. Piercing ofthe cell
membrane causes rapid deregulation of ionic pumps, rapid influx ofcalcium ions, and
immediate cell lysis [24].
In summary, the pleomorphic appearance of the liver parenchyma in acute viral
hepatitis B seems to reflect a multitude of immunological mechanisms, apparently at
work simultaneously or in sequence to eliminate virus-supporting hepatocytes. These
mechanisms include: activation of antigen-presenting cells (macrophages), focal
apoptosis mediated by infiltrating NK lymphocytes and cytotoxic T lymphocytes, and
ballooning of hepatocytes, eventually followed by confluent lytic necrosis, presumably
brought about by humoral mechanisms.
The viral antigen(s) which function(s) as target antigen(s) for the immune
elimination is (are) not so extensively studied in acute as in chronic hepatitis B; the
obvious reason is that diagnostic liver biopsies are usually not taken during the
incubation period, but rather at the height oftransaminase elevation.
In this fully developed stage of acute hepatitis, only little or no HBsAg or HBcAg
can be demonstrated in the liver. This state is consistent with the concept that acute
hepatitis B is an "elimination type" ofdisease, resulting in eradication ofthe virus and
assuring a self-limited course of the disease [8]. The necrotic hepatocytes are
phagocytosed by Kupffer cells, which acquire a bulky cytoplasm, loaded with coarse,
golden-yellow PAS-positive and diastase-resistant pigment granules termed ceroid
pigment. These ceroid-laden macrophages tend to cluster in the parenchyma and
finally migrate toward the portal tracts. The loss ofparenchymal cells is compensated
for by hepatocellular regeneration, which usually leads to complete "restitutio ad
integrum" in uncomplicated acute viral hepatitis B.
CHRONIC VIRAL HEPATITIS B
In about 10 percent of patients infected with HBV, the disease which develops
corresponds to chronic hepatitis (Fig. 1).
CLASSIFICATION OF CHRONIC HEPATITIS
Histologically, the term chronic hepatitis refers to a broad spectrum of hepatic
inflammatory conditions, ranging from near-normal liver histology to complete
cirrhotic transformation of the liver architecture. Classification remains a problem,
because of the multiplicity of simultaneous lesions, the imprecise borderline between
subgroups, the subjective evaluation of individual tissue alterations, the problem of
sampling error, and terminologic confusion.
In 1968, an international Liver Study Group proposed a very simple classification of
chronic hepatitis [31]. Distinction was made between chronic persistent hepatitis, a
milder form of disease with better prognosis, and chronic aggressive hepatitis, a more
severe category of disease with frequent evolution into cirrhosis. This classification
emphasized piecemeal necrosis (see below) as the important histological hallmark of
progressive forms ofchronic hepatitis.
In contrast, Dr. Gerald Klatskin and his colleagues from Yale maintained that the
real pacemaker for cirrhogenic evolution is bridging hepatic necrosis [32-35]. This
controversy became the subject of a long debate. Patterns and extent of piecemeal
necrosis and bridging hepatic necrosis were examined in several studies which also
intended to evaluate the use ofsteroid treatment.
These studies were evaluated in a recent editorial in Hepatology [36], ending with
the main conclusion that in fact the problem is not finally settled: larger and better
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stratified series ofpatients need to be studied. Nevertheless, a unifying picture seems to
emerge in that both piecemeal necrosis and bridging hepatic necrosis are prognosti-
cally important lesions. The concept that lobular necro-inflammatory lesions, espe-
cially more extensive bridging necrosis, characterize more severe variants of the
disease, was incorporated in further classifications of chronic hepatitis [37-39].
As a result ofongoing studies, recent schemes ofchronic hepatitis have become more
complicated but still distinguish between milder forms and more severe variants of the
disease (Table 1) [40].
The prototype form of mild chronic viral hepatitis is chronic persistent hepatitis.
Histologically, this condition corresponds to "portal" hepatitis [41]. The portal tracts
are infiltrated by lymphoid cells, which remain confined within the limits of the portal
connective tissue. The lobular parenchyma shows minimal lesions: occasional focal
necrosis and rare apoptotic bodies.
The more severe category of chronic hepatitis (chronic active or aggressive
hepatitis) comprises several variants with different degrees of liver damage, all
characterized by piecemeal necrosis (Table 1).
In mild to moderate chronic aggressive hepatitis, the predominant lesion is peripor-
tal piecemeal necrosis; the lobular parenchyma shows only minor changes, including
some scattered foci offocal necrosis. This type of chronic hepatitis, although mild, may
slowly progress into cirrhosis [42].
More severe variants of chronic aggressive hepatitis show a more complex histologic
picture; not only is piecemeal necrosis more extensive, but in addition the lobular
lesions are impressive and may include bridging hepatic necrosis (Table 1).
Bridging hepatic necrosis obviously entails more extensive and more rapid dissection
of the lobular architecture. The most severe form of confluent lytic necrosis, i.e.,
multilobular necrosis, may be an especially ominous feature [43]. Dr. G. IKlatskin and
his colleagues deserve the credit for having emphasized the fundamental importance of
bridging hepatic necrosis in accelerating the evolution of chronic hepatitis into
cirrhosis [32-35].
Collapse of the reticulin framework in areas of extensive confluent necrosis leads to
the formation of fibrous scars; these can be considered as "passive" septa, since they
derive primarily from passive collapse of a denudated frame of fibers with subsequent
new collagen formation [25]. Passive septa show an excess of fibers over cells; they are
paucicellular septa, carrying little inflammatory infiltration, and remain sharply
delineated from the surrounding parenchyma. This appearance is in contrast to
extending wedges of piecemeal necrosis, rich in cells and poorly delineated, which have
been termed active septa.
NATURAL HISTORY OF CHRONIC VIRAL HEPATITIS B
For several years, classification of chronic hepatitis has been the decision base for
starting treatment with steroids and/or immunosuppressives. This procedure is no
longer the case for chronic viral hepatitis type B [44].
Histological definition of the degree of disease activity and the stage of progression
of the disease remains, however, important in the light of newer insights into the
natural history of the disease.
From several studies [5,45,46] it appeared that three phases can be recognized over
the years during the long course of chronic hepatitis B.
In the first phase, which can be considered as a period of "immune tolerance" to the
HBV, extensive viral replication takes place; this process is reflected in positive
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serological reactions for HBeAg, hepatitis B viral DNA, and DNA polymerase
activity. Biochemically, the disease is mild, without marked elevation oftransaminase
levels. Histologically, the liver biopsy reveals only low inflammatory activity, corre-
sponding to chronic persistent hepatitis or non-specific reactive hepatitis.
This form of chronic persistent hepatitis is of the so-called HBcAg-predominance
type [47]: the majority ofthe hepatocytes are positively stained for HBcAg, mainly in
their nuclei, and HBsAg is often found in a membranous localization in the liver cell
membranes. Nuclei which are overloaded with HBcAg show on hematoxylin-eosin
stained sections a peculiar appearance, described as "sanded nuclei" [48]. This stage
represents the high-replicative phase ofchronic hepatitis.
After some time, and for reasons unknown, the immune system succeeds in
eliminating substantial numbers of virus-infected cells. This phase can be considered
the "immune-clearance" phase of the disease, characterized by low levels of viral
replication and in many patients byseroconversion from HBeAg to anti-HBeantibody.
This phase is preceded by or associated with a flare-up of transaminases and is
characterized histologically by more impressive parenchymal lesions, recognizable as
chronic lobular or chronic active hepatitis. The episode of parenchymal necrosis may
bequite severe, with multiple areas offocal necrosis and even bridging hepatic necrosis
[49]. Such a necrotizing episode may turn the liver into cirrhosis.
The ensuing third phase is the "non-replicative" phase: one finds no more signs of
viral replication and the patient is anti-HBe antibody-positive. Transaminases are only
slightly elevated, and, accordingly, liver histology reveals only mild inflammatory
lesions of chronic persistent hepatitis. This form of chronic persistent hepatitis is,
however, ofthe so-called HBsAg-predominance type [47]: large numbers ofparenchy-
mal cells display a massive accumulation ofHBsAg in the cytoplasm, and only few or
no nuclei are positive for HBcAg. Such parenchymal cells, containing large amounts of
HBsAg in their endoplasmic reticulum, represent the so-called ground-glass hepato-
cytes [50]. It should be emphasized, however, that the ground-glass appearance of
hepatocytes may also be caused by other mechanisms [51].
Apparently, several virus-infected cells have escaped immune elimination. This
condition might be due to defective display of viral antigens at the liver cell surface,
inadequate display of HLA class I antigens, or masking of membrane-expressed viral
antigen(s) by antibody (Fig. 2).
Several studies [52,53] indicate that the latter mechanism is operating in chronic
hepatitis B: HBcAg-positive liver cells are covered with immunoglobulin IgG which
could be shown to have anti-HBc antibody specificity. This condition adds to the
complexity of phenomena occurring in the liver in HBV infection and is part of a
complex network ofimmunomodulation (Fig. 2).
NECRO-INFLAMMATORY LESIONS IN CHRONIC ACTIVE VIRAL
HEPATITIS B
Piecemeal Necrosis
Piecemeal necrosis is not unlike interphase dermatitis, observed, for example, in
lichen ruber planus or phototoxic dermatitis [54]. In these conditions, mononuclear
inflammatory cells concentrate at the interphase between epidermal keratinocytes and
dermal connective tissue. The infiltrate is predominantly composed of helper T
lymphocytes in the derma, whereas cytotoxic T cells infiltrate between the epidermal
keratinocytes, which undergo individual acidophil necrosis (so-called Civatte bodies).
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The numberofepidermal, HLA class II antigen-positiveLangerhans cells is increased,
whereas the keratinocytes themselves show increased expression of HLA class I
antigens [55] and de novo display of HLA class II antigens [56]. The whole process
causes an indistinct borderline between epidermis and derma.
Interphasedermatitis represents a cell-mediated immunological reaction, associated
with destruction ofepidermal keratinocytes. The antigen against which the reaction is
mounted remains unknown.
Piecemeal necrosis in the liver can also be described as an interphase hepatitis [57].
Here also the epithelial-mesenchymal borderline is blurred, lymphocytes invade the
epithelial territories, and some hepatocytes appear as acidophil bodies (Fig. 10).
The predominant type of lymphocyte in the invading fronts of piecemeal necrosis is
the OKT8+ suppressor/cytotoxic T lymphocyte, whereas OKT4+ helper/inducer T
lymphocytes are more numerous in the central area of the portal connective tissue
[58].
Some of the portal and periportal mononuclear cells do not correspond to lympho-
cytes but represent accessory cells, reticulum cells, or antigen-presenting cells.
One type of reticulum cell shows the ultrastructural features of follicular dendritic
cells which are well known in the lymph follicles or so-called B areas of lymphoid
tissues like lymph nodes and spleen. They are mainly found in the central parts of
portal tracts [58,59].
In the peripheral areas of piecemeal necrosis, another type of reticulum cell can be
observed. It has the electron microscopic features of interdigitating reticulum cells,
which were often described in the paracortical areas or so-called T zones of lymph
nodes [59]. These cells are the homologues of the Langerhans cells in the skin.
Dendritic and interdigitating reticulum cells appear to function as antigen-presenting
cells, respectively, for B and T lymphocytes [60].
The morphological similarity of these reticulum cells to those observed in lymph
nodes and spleen, and their preferential localization in central or peripheral areas of
piecemeal necrosis, allow us to consider the central part of the portal tract as the B
zone, and the invading periphery as the T zone of piecemeal necrosis [58].
Endothelial cells also play an important role in immunological reactions. One ofthe
crucial features is to influence the exit of lymphocytes from blood to interstitium. In
areas of piecemeal necrosis, numerous lymphocytes are crowded together (Fig. 10),
suggesting that the capillaries in those areas must be a preferential zone of exit from
blood to tissue, not unlike the high-endothelial venules in the paracortical areas of
lymph nodes.
Ultrastructural investigation of piecemeal necrosis reveals that in these areas the
sinusoidal lining endothelial cells lose their fenestrae, show swelling oftheir cytoplasm,
and accumulate electron-dense granules, assuming morphological features resembling
those of the lining cells in high-endothelial venules [61,62]. Such transformed
endothelial cells presumably may further change into so-called fibroblastic reticulum
cells, which are thought to be involved in collagen production. As such, these
phenotypic shifts of endothelial cells may represent a link between inflammation and
fibroplasia in piecemeal necrosis [58,61].
Liver parenchymal cells show marked changes in expression of HLA antigens in
areas of piecemeal necrosis. Normal hepatocytes do not express HLA-ABC antigens;
in areas of piecemeal necrosis, however, liver parenchymal cells do display these
antigens at their surface [9]. In the same areas, hyperplastic sinusoidal lining cells,
76LIVER LESIONS IN HEPATITIS B VIRAL INFECTION 77
dc d
~0
0.
4-.
*. 0V.J. DESMET
strongly positive for HLA class II antigens, are found to encircle hepatocytes [9]. The
meaning of increased hepatocellular HLA class I antigen expression may be that
nearby cytotoxic T lymphocytes have to "see" their target antigen in conjunction with
HLA class I antigens; the activation and proliferation ofthesecytotoxic T cells may be
enhanced by increased HLA-DR (class II) antigen expression on the surrounding
sinusoidal lining cells [9].
The mode of cell death of the target hepatocytes in piecemeal necrosis appears to
correspond to apoptosis [63].
The nature of the target antigen is not known. Apparently, it is not a viral antigen,
since neither HBcAg nor HBsAg are preferentially localized in zones of piecemeal
necrosis. Some studies suggested that the target antigen may be a self-antigen, termed
liver membrane antigen [64]. The latter studies, however, indicate that the effector
cells are not cytotoxic T cells, but rather killer cells involved in antibody-dependent
cellular cytotoxicity.
It is not impossible that both T-cell cytotoxicity and antibody-dependent killer cell
activity occur together in piecemeal necrosis.
Focal Necrosis
Much attention has been focused on the mechanism ofelimination ofvirus-infected
cells in chronic hepatitis, causing lobular parenchymal damage and necrosis appearing
as focal or spotty necrosis.
Functional immunologic studies [52,65-66] have indicated that in chronic viral
hepatitis B, focal necrosis is due to cell-mediated immunity, with cytotoxic T
lymphocytes functioning as effector cells against viral nucleocapsid antigen (HBcAg
and/or HBeAg) as the target antigen.
Immunohistochemical studies on tissue sections [67] reveal that, in areas of focal
necrosis, the infiltrating lymphocytes are OKT8+ suppressor/cytotoxic cells; hepato-
cytes in these foci display not only HLA class I, but also HLA class II antigens on their
membrane, and often contain HBcAg in their nuclei, cytoplasm, and plasma
membrane [67]. Immuno-electron microscopy allows us to confirm that HLA class II
antigen [67] and HBcAg [68,69] are indeed expressed at the level of the liver cell
plasma membrane.
These results are consistent with the conclusions obtained from functional immuno-
logical studies that HBcAg is a target antigen, against which effector cytotoxic T cells
react when it is expressed together with HLA class I antigens at the liver cell
membrane (Fig. 2). The meaning ofhepatocellular HLA class II antigen expression is
not readily explained, although this expression may allow the hepatocyte to present the
viral antigen(s) to T lymphocytes, thus enhancing the immunological response. The
"aberrant" expression ofHLA class II antigens on epithelial cells has been observed in
other tissues as well and indicates that antigen presentation may not be exclusively a
function ofantigen-presenting reticulum cells [67].
IMMUNOMODULATION IN CHRONIC VIRAL HEPATITIS B
In addition to immunomodulation by anti-HBc antibody, further immunomodula-
tion is brought about by interferons. Alpha interferon from different cellular sources
may influence expression of viral antigens and enhance the display of HLA class I
antigens [70]. Gamma interferon, produced by sensitized T lymphocytes, may induce
enhanced expression of HLA class I and class II antigens on hepatocytes [12,67].
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Further components in immunomodulation are immunoregulatory molecules. One
such factor is a lipoprotein termed rosette inhibitory factor (RIF) [71]. Incorporation
of the HBV genome into infected hepatocytes induces a state of disordered liver cell
metabolism, resulting in the induction of abnormal immunoregulatory molecules
(including RIF), which are responsible for inhibition of normal suppressor cell
function, resulting, in turn, in antibody responses to autologous molecules such as
actin, liver specific protein (LSP), and liver membrane antigen (LMA) [72] (Fig. 2).
Factors such as Lex (liver extract) [71,73], LIP (liver immunoregulatory protein)
[74], and another LIP (liver-derived inhibitory protein) [75] may be responsible for
inhibition of cytotoxic effector lymphocytes near necrotizing hepatocytes. Such
immune inhibitory effect of factors released from damaged hepatocytes may confine
the inflammatory reaction within restricted tissue areas and help to explain the
topographical restriction of necro-inflammatory lesions like piecemeal necrosis and
focal necrosis in chronic hepatitis B.
CIRRHOSIS
Continuous or relapsing parenchymal damage in chronic hepatitis B is followed by
parenchymal regeneration. The development of active and passive septa causes
disturbances in the normal spatial relationship between hepatic parenchyma and
interstitial connective tissue. Parenchymal regeneration in a nodular fashion, in
between the restructured or restructuring fibrous scaffold, leads to progressive
development ofcirrhosis (Fig. 1).
Post-hepatitic cirrhosis is often of the macronodular variety, characterized by
irregular size of the parenchymal nodules and a variable thickness of the fibrous
septa.
Even in the cirrhotic stage, the necrotizing and inflammatory process may continue
to operate in the already altered and architecturally ruined liver; this situation
corresponds to "active" cirrhosis. In liver biopsies from these patients, signs ofactivity
are reflected in the same histological features which also characterize chronic active
hepatitis in the non-cirrhotic stage: that is, piecemeal necrosis, spotty necrosis, and
confluent necrosis [40].
HEPATOCELLULAR CARCINOMA
Evidence has become compelling that HBV is an important etiological factor in the
causation ofprimary hepatocellular carcinoma [76] (Fig. 1).
Integration ofviral DNA into the host DNA ofsomeimmune-protected hepatocytes
is thought to represent the initiation factor in the sequence ofevents that finally result
in the development ofhepatocellular carcinoma [77]. Initially, integration is a random
event, with random insertion of random viral DNA segments into cellular DNA. It is
followed by gene rearrangements (duplication, deletion, and so on) of viral and host
DNA, leading to altered gene expression and cellular transformation [77]. Cycles of
cellular necrosis due to the hepatitic process and ensuing regeneration are believed to
fulfill the role ofpromotion [78].
After a long period ofselection, a clonal proliferation ofcells ensues, endowed with
properties of unlimited proliferation and immortality. This stage represents the early
stage ofmalignant growth.
It may occur in non-cirrhotic liver, as is often the case in patients from Africa and
the Far East, representing areas with high endemicity of HBV, where infection often
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occurs in the perinatal period. In the Western world, hepatocellular carcinoma
develops more often on a background of cirrhosis. The tumor cells contain integrated
viral DNA but express HBsAg only to a limited extent, and even less HBcAg.
Dysplastic liver cells represent a cellular lesion which has been considered a
histological precursor lesion of malignant hepatocytes [79]. Such liver parenchymal
cells are mainly characterized by enlargement, irregular size, and hyperchromatic
staining oftheir nuclei. They are frequently observed in HBsAg-positive liver cirrhosis
and may occasionally themselves express HBsAg. Whether dysplastic liver cells truly
represent a precursor stage of malignant transformation of hepatocytes remains a
matter ofdebate [80].
Early foci of hepatocellular carcinoma may be difficult to diagnose in biopsy
specimens from a cirrhotic liver. It would be useful to dispose of reliable markers of
malignant hepatocytes. Immunohistochemical staining for hepatic transferrin receptor
has been suggested as a useful diagnostic tool [81] which merits further investigation.
CONCLUSION
In conclusion, infection with HBV may lead to a wide spectrum of liver lesions,
including diverse cytological alterations, various types and patterns of necrosis,
different modes ofinflammatory infiltration, normal and aberrant patterns ofregener-
ation and hyperplasia, variable degrees and patterns of fibrosis, including the
irreversible stage of liver cirrhosis, and even malignant transformation of hepato-
cytes.
I had the good fortune todiscuss several ofthese lesions with Dr. Gerald Klatskin on
multiple occasions, usually during coffee breaks and social parties at liver meetings. I
learned a lot from his distinctive stories and detailed descriptions. Dr. G. Klatskin not
only was a leader in clinical hepatology but also a most competent student with
encyclopedic knowledge ofmicroscopic liver changes.
With great affection and deep gratitude, I dedicate this review of "liver lesions in
hepatitis B virus infection" to the memory ofthe legendary Dr. Gerald Klatskin.
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